BRIEF

on Research Dynamics

CPH Group Navigates Mixed Markets Amid Strategic Expansion

CPH Group reported a slight decrease in net sales for the first half of 2025, at CHF 176.0 million, down 0.5% year-on-year. The group's EBITDA remained stable at CHF 30.2 million, maintaining a margin of 17.2%. Challenges included currency headwinds and higher costs following a division spin-off. EBIT saw a decline of 6.8% to CHF 21.9 million, affected by acquisition-related depreciation. The net result was CHF 17.1 million, a drop attributed to prior-year one-off gains and increased acquisition financial costs.

Zeochem's net sales fell 7.2% due to lower demand and FX effects, despite strong performance in high-value molecular sieves. Perlen Packaging saw a 3.1% sales increase with improving order volumes and stable PVC prices. Looking ahead, CPH foresees potential growth in the second half, contingent on overcoming existing economic challenges.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Research Dynamics news